<--- Back to Details
First PageDocument Content
Clinical research / Pharmaceutical industry / Therapeutics / United States Public Health Service / Drug development / Center for Drug Evaluation and Research / Criticism of the Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Food and Drug Administration
Clinical research
Pharmaceutical industry
Therapeutics
United States Public Health Service
Drug development
Center for Drug Evaluation and Research
Criticism of the Food and Drug Administration
Pharmaceutical sciences
Pharmacology
Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 13,25 KB

Share Document on Facebook

Similar Documents

CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017

DocID: 1ueGS - View Document

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEW

DocID: 1t19G - View Document

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEW

DocID: 1sZi5 - View Document

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

DocID: 1sPXO - View Document

Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire A

DocID: 1swgc - View Document